Medicine Description cyklokapron 500mg
Cyklokapron 500mg Ampoules is a medication that contains tranexamic acid, which is an antifibrinolytic agent. Its primary mechanism involves the inhibition of plasminogen activation to plasmin, a protein responsible for breaking down fibrin in blood clots. By preventing the conversion of plasminogen to plasmin, tranexamic acid effectively stabilizes clots and reduces excessive bleeding. This action is particularly beneficial in conditions where there is an increased tendency for bleeding due to inadequate clot formation or excessive clot breakdown. The medication is rapidly absorbed upon administration and exerts its effect within hours, making it useful in both acute and chronic bleeding scenarios.
Indications and Uses of Cyklokapron 500mg Ampoules
- Management of heavy menstrual bleeding (menorrhagia).
- Reduction of bleeding during and after surgical procedures.
- Treatment of recurrent epistaxis (nosebleeds).
- Support in patients with hemophilia to minimize bleeding episodes.
- Assistance in postoperative bleeding following dental procedures.
- Control of bleeding associated with childbirth or miscarriage.
Side Effects of Cyklokapron 500mg Ampoules
- Nausea and vomiting.
- Diarrhea.
- Abdominal discomfort.
- Headache.
- Dizziness.
- Visual disturbances, such as changes in color vision.
- Allergic reactions including skin rash or itching.
- Thrombosis and thromboembolic events in predisposed individuals.
Storage and Handling
Store Cyklokapron 500mg Ampoules at room temperature, away from direct sunlight and moisture. Keep out of reach of children. Do not freeze or refrigerate.
Patient Advice and Precautions
Patients should be advised to stay well-hydrated during treatment. It is important to inform healthcare providers about any history of thromboembolic disorders before starting therapy. Individuals should also report any unusual symptoms such as chest pain, swelling, or difficulty breathing. Regular monitoring may be necessary for those with underlying health conditions or those taking other medications that affect clotting.